We aimed to quantify the incidence of atrial fibrillation (AF) in patients with cryptogenic stroke globally, as well as separately in patients in and outside of Japan, using an implantable loop ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...

“As a result of this accelerated conversion, we now expect PFA to likely exceed our previously communicated range of 40% to 60% of global afib ablations by 2026.” Boston Scientific also ...

The incidence of atrial fibrillation (AF) is on the rise, and recent joint guidelines from the American College of Cardiology and American Heart Association (ACC/AHA) stress the role of primary ...

In this installment of Atrial Fibrillation (AFib) and Antiarrhythmic Drugs (AADs) series, Dr. Suneet Mittal interviews Dr. Jeff Healey about evidence supporting the guidelines and how they compare to ...

Last month a 33-year-old woman in Xi’an, in central China, posted a video on social media that showed snowflakes falling on the ancient city. It was early in the year for such weather, so ...

Atrial fibrillation, or AFib is the most common type of heart arrhythmia. It’s estimated 12 million people in the U.S. are living with it. If not treated, it can lead to blood clots and stroke.

The goal of the TIGHT K trial was to evaluate if prescribing relaxed control of potassium levels and only giving supplements in the rare event that levels became pathologically low was equally as ...